AU2002212107A1 - New multimeric interferon beta polypeptides - Google Patents
New multimeric interferon beta polypeptidesInfo
- Publication number
- AU2002212107A1 AU2002212107A1 AU2002212107A AU1210702A AU2002212107A1 AU 2002212107 A1 AU2002212107 A1 AU 2002212107A1 AU 2002212107 A AU2002212107 A AU 2002212107A AU 1210702 A AU1210702 A AU 1210702A AU 2002212107 A1 AU2002212107 A1 AU 2002212107A1
- Authority
- AU
- Australia
- Prior art keywords
- interferon beta
- beta polypeptides
- multimeric
- new
- new multimeric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200001646 | 2000-11-02 | ||
DKPA200001646 | 2000-11-02 | ||
PCT/DK2001/000723 WO2002036628A2 (en) | 2000-11-02 | 2001-11-01 | New multimeric interferon beta polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002212107A1 true AU2002212107A1 (en) | 2002-05-15 |
Family
ID=8159820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002212107A Abandoned AU2002212107A1 (en) | 2000-11-02 | 2001-11-01 | New multimeric interferon beta polypeptides |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1334128A2 (en) |
AU (1) | AU2002212107A1 (en) |
WO (1) | WO2002036628A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003254641A1 (en) * | 2002-08-28 | 2004-03-19 | Maxygen Aps | Interferon beta-like molecules for treatment of cancer |
KR20050059195A (en) * | 2002-09-27 | 2005-06-17 | 바이오겐 아이덱 엠에이 인코포레이티드 | THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-β |
FR2851471B1 (en) * | 2003-02-24 | 2006-07-28 | Synt Em | COMPOUNDS COMPRISING AT LEAST ONE ACTIVE SUBSTANCE AND AT LEAST ONE VECTOR CONNECTED BY A BINDING AGENT, USES THEREOF AND THE BINDING AGENTS |
AU2005209926B2 (en) * | 2004-02-02 | 2007-09-06 | Ambrx, Inc. | Modified human four helical bundle polypeptides and their uses |
GB0405634D0 (en) | 2004-03-12 | 2004-04-21 | Univ Southampton | Anti-virus therapy for respiratory diseases |
US7625555B2 (en) | 2007-06-18 | 2009-12-01 | Novagen Holding Corporation | Recombinant human interferon-like proteins |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0237019A3 (en) * | 1986-03-14 | 1988-03-09 | Toray Industries, Inc. | Interferon conjugate and production thereof using recombinant gene |
US5919758A (en) * | 1994-03-22 | 1999-07-06 | Beth Israel Deaconess Medical Center | Modified polypeptides with altered biological activity |
US5723125A (en) * | 1995-12-28 | 1998-03-03 | Tanox Biosystems, Inc. | Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
US6187564B1 (en) * | 1997-07-10 | 2001-02-13 | Beth Israel Deaconess Medical Center | DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics |
WO1999003887A1 (en) * | 1997-07-14 | 1999-01-28 | Bolder Biotechnology, Inc. | Derivatives of growth hormone and related proteins |
EP1121382B9 (en) * | 1998-10-16 | 2007-07-04 | Biogen Idec MA Inc. | Interferon-beta fusion proteins and uses |
NZ510689A (en) * | 1998-10-16 | 2003-07-25 | Biogen Inc | Polymer conjugates of interferon beta-1a and uses |
MXPA02001969A (en) * | 1999-08-27 | 2003-07-21 | Maxygen Aps | New interferon betalike molecules. |
-
2001
- 2001-11-01 EP EP01980206A patent/EP1334128A2/en not_active Withdrawn
- 2001-11-01 AU AU2002212107A patent/AU2002212107A1/en not_active Abandoned
- 2001-11-01 WO PCT/DK2001/000723 patent/WO2002036628A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002036628A3 (en) | 2003-01-03 |
EP1334128A2 (en) | 2003-08-13 |
WO2002036628A2 (en) | 2002-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG85204A1 (en) | Sintered materials | |
AU2705201A (en) | Ceramic structure | |
AU5617900A (en) | Chimeric chemokine-antigen polypeptides and uses therefor | |
AU2002212108A1 (en) | Single-chain multimeric polypeptides | |
GB9921125D0 (en) | Proteins | |
AU2001284418A1 (en) | Novel polypeptide | |
PL373008A1 (en) | Cytokine polypeptides | |
AU2002212107A1 (en) | New multimeric interferon beta polypeptides | |
AU2002241899A1 (en) | Tip39 polypeptides | |
AU2001288220A1 (en) | Hyperglycosylated polypeptides | |
AU7049601A (en) | Ceramic material | |
AU1881200A (en) | Novel proteins | |
AU6983000A (en) | Chimeric proteins | |
AU4778600A (en) | Novel polypeptide | |
AU6712600A (en) | Polypeptides | |
AU1686701A (en) | Dispatched polypeptides | |
AU2002240889A1 (en) | Proteins that interact with betatrcp | |
GB0125093D0 (en) | Multimeric proteins | |
AU2002224056A1 (en) | Novel polypeptide | |
AU3242200A (en) | Pyk2 binding proteins | |
AU2574100A (en) | Novel cytokine recfptor-like protein | |
GB9923932D0 (en) | Multimeric proteins | |
AU4853301A (en) | Genetic factor affecting cytokine expression | |
AU2002225532A1 (en) | Silver-dispersing polypeptides | |
GB0018307D0 (en) | Polypeptides |